Kronos Bio Shareholder Drops Suit as Concentra Buyout Completes

A Kronos Bio Inc.‘s stockholder relinquished her lawsuit alleging that the struggling company’s sale to Concentra Biosciences LLC was misleadingly contrived as the company has told the Securities and Exchange Commission the deal closed.

Investor Susan Bowen told the US District Court for the Northern District of California she was dropping her claims that Kronos’ acquisition paperwork misrepresented the sales process and potential conflicts of interest on Wednesday. It follows the merger’s closing on June 20, according to an SEC filing from last week. Bowen’s complaint had sought an injunction blocking the merger, or an order rescinding the ...